Shorepower Technologies Announces Transformative Merger with Aeternum Health, Pivoting to Healthcare Amidst Going Concern Warning

summarizeSummary

Shorepower Technologies is undergoing a complete transformation, announcing a reverse merger with Aeternum Health LLC to pivot from transportation electrification to healthcare, while simultaneously addressing a 'going concern' warning and internal control weaknesses.

check_boxKey Events

• Proposed Reverse Merger and Business Pivot

  The company has entered into a merger agreement with Aeternum Health LLC, under which Shorepower will divest its current transportation electrification business and shift its focus entirely to healthcare, specifically longevity and anti-aging solutions. The company will change its name to Aeternum Health.

• Change of Control and Management

  Upon closing, current CEO Jeff Kim will resign, and Paul Mann (Aeternum Health's manager) will be appointed as the new President, CEO, and sole director. Paul Mann will receive shares representing 51% ownership and 2,000,000 shares of Series B preferred stock with super voting rights.

• Significant Capital Infusion and Share Restructuring

  Aeternum Health will contribute at least $1.5 million in cash. Additionally, outgoing CEO Jeff Kim has agreed to cancel up to 13,000,000 common shares in stages. The company also plans to increase its authorized common shares from 100 million to 250 million, representing substantial potential future dilution.

• Going Concern Warning and Internal Control Weaknesses

  The auditor raised substantial doubt about the company's ability to continue as a going concern, citing a cash balance of $15,374, negative working capital of $1,080,208, and an accumulated deficit of $3,278,141 as of December 31, 2025. Management also reported ineffective disclosure controls and material weaknesses in internal controls.

auto_awesomeAnalysis

This 10-K filing reveals a complete strategic overhaul for Shorepower Technologies, highlighted by a proposed reverse merger with Aeternum Health LLC. The company plans to divest its existing transportation electrification business and pivot entirely into the healthcare sector, focusing on longevity and anti-aging solutions. This is a thesis-altering event, as it fundamentally changes the company's business, management, and risk profile. While the merger brings a much-needed cash infusion of at least $1.5 million and a significant share cancellation by the outgoing CEO (up to 13 million shares), it also introduces substantial uncertainty associated with entering a new, unrelated, and speculative industry. Furthermore, the company's financial statements for the period ending December 31, 2025, include a 'going concern' warning from its auditor, citing a cash balance of only $15,374, negative working capital, and an accumulated deficit. Management also reported ineffective disclosure controls and material weaknesses in internal controls, raising concerns about financial reporting reliability. The planned increase in authorized shares from 100 million to 250 million represents a massive potential for future dilution, which could significantly impact existing shareholders.